Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.

Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE.

J Am Heart Assoc. 2019 Jul 16;8(14):e011706. doi: 10.1161/JAHA.118.011706. Epub 2019 Jul 15.

2.

The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.

Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM.

Kidney Int. 2019 Aug;96(2):470-479. doi: 10.1016/j.kint.2019.03.024. Epub 2019 May 7.

PMID:
31262489
3.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
4.

The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.

Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N.

Clin Transplant. 2014 Aug;28(8):845-54. doi: 10.1111/ctr.12389. Epub 2014 Jun 24.

PMID:
24869763
5.

Vascular access thrombosis and interventions in patients missing hemodialysis sessions.

Shah R, Bhatt UY, Cleef SV, Farley M, Davis A, Swope M, Agarwal AK.

Clin Nephrol. 2011 Dec;76(6):435-9.

PMID:
22105445
6.

Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock.

Parikh S, Nijmeh R, Van Cleef S, Timmerman S, Bhatt UY, Agarwal AK.

Semin Dial. 2012 May;25(3):351-6. doi: 10.1111/j.1525-139X.2011.00966.x. Epub 2011 Nov 10.

PMID:
22074231
7.

A modest proposal for improving the accuracy of creatinine-based GFR-estimating equations.

Hebert PL, Nori US, Bhatt UY, Hebert LA.

Nephrol Dial Transplant. 2011 Aug;26(8):2426-8. doi: 10.1093/ndt/gfr151. Epub 2011 Mar 29. No abstract available.

8.

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA.

Kidney Int. 2011 Jul;80(2):181-9. doi: 10.1038/ki.2011.44. Epub 2011 Mar 9.

9.

Blood culture isolates in hemodialysis vascular catheter-related bacteremia.

Alexandraki I, Sullivan R, Zaiden R, Bailey C, McCarter Y, Khan A, Offutt JK, Bhatt UY, Plott D, Nahman NS Jr.

Am J Med Sci. 2008 Oct;336(4):297-302. doi: 10.1097/MAJ.0b013e3181637432.

PMID:
18854670
10.

Glomerular beta-galactosidase expression following transduction with microsphere-adenoviral complexes.

Bhatt UY, Sferra TJ, Johnson A, Williams C, Shirey K, Venema T, Nuovo GJ, Nahman NS Jr.

Kidney Int. 2002 Jan;61(1 Suppl):S68-72.

Supplemental Content

Loading ...
Support Center